Liver disease drug could be converted to protect against COVID, study finds

Liver disease drug could be converted to protect against COVID, study finds

Almost three years after the pandemic, we are still regularly recording hundreds of thousands of new cases of COVID every day around the world. In a new study involving a combination of miniature organ models, donor organs, animals and humans, we show that a drug used to treat liver disease could be repurposed to protect against COVID-19.

This drug could be effective regardless of the variant of COVID. Explode/Shutterstock

Vaccines are one of the most effective weapons in our pandemic response, but not everyone can benefit from them. COVID vaccines work by training our immune system to recognize and destroy SARS-CoV-2, the virus that causes COVID-19. As such, they are not effective in people with poorly functioning immune systems, such as patients taking immune-suppressing drugs after an organ transplant.

#Liver #disease #drug #converted #protect #COVID #study #finds

Leave a Comment

Your email address will not be published. Required fields are marked *